0 items USD 0.00Search
Your search for "delveinsight ankylosing spondylitis bekhterevs disease global api manufacturers marketed phase" gave back 1549440 results.
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Summary Publisher estimates that the Musculoskeletal Disorders Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by...
Catalog:
HYR
April 2021
Price: USD 2,000.00
Summary The Musculoskeletal Disorders Therapeutics market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of...
Catalog:
HYR
March 2021
Price: USD 2,000.00
According to our Publisher latest study, the global Systemic Autoimmune Disease Diagnostics market size was valued at USD million in 2022 and is...
Catalog:
GIR
January 2023
Price: USD 3,480.00
The global PDE 4 Inhibitors market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of %...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Humira Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it is expected to grow at...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The global Infliximab Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (...
Catalog:
GIR
March 2023
Price: USD 4,480.00
The global Musculoskeletal Disorders Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global PDE 4 Inhibitors market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-...
Catalog:
GIR
August 2023
Price: USD 4,480.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
TNF Alpha Inhibitor are a group of medicines that suppress the body's natural response to tumor necrosis factor (TNF), a protein produced by...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
